could show that the immunoproteasome subunit LMP7 was absolutely required for the generation of LCMV GP 118-125 -specific T cells although the class I mediated presentation of GP 118-125 was not dependent on LMP7. Using bone marrow chimeras and adoptive transfer of LMP7-deficient CD8 + T cells into RAG1-deficient mice we show that LMP7-deficient mice lacked GP 118-125 -specific T cell precursors and that LMP7 was required in radioresistant cells -most likely thymic epithelial cells -to enable their selection. Since LMP7 is strongly expressed in negatively selecting mTECs but barely in positively selecting cTECs our data suggest that LMP7 was required to avoid excessive negative selection of GP 118-125 -specific T cell precursors. Taken together, this study demonstrates that the immunoproteasome is a crucial factor for filling up holes within the cytotoxic T cell repertoire.
Introduction
The proteasome is the main protease responsible for generating ligands for MHC class I molecules for the presentation to cytotoxic T lymphocytes (CTLs) [1, 2] . The proteolytic core complex of the proteasome system is the 20S proteasome, which possesses a bar-T cell expansion [13, 14] , in the protection from immunopathological damage in the brain [15, 16] , and in autoimmune diseases [17] [18] [19] [20] [21] [22] [23] . Immunoproteasome-deficient mice have been used to investigate the impact of the inducible proteasome subunits in various studies (reviewed in [24] ). Apart from defects in class I antigen presentation, LMP7-deficient mice show alterations in the clearance of Listeria monocytogenes [25] , in Toxoplasma gondii infection [26] , in murine cytomegalovirus (MCMV) infection [27, 28] , in Trypanosoma cruzi infection [29] , and in experimental colitis [18, 30, 31] . Cells from LMP7
−/− mice [32] express reduced levels of surface MHC-I molecules [17, 32] , emphasizing the crucial role of LMP7 in MHC-I restricted antigen processing. It has recently been reported that differences in MHC-I presentation between standard and immunoproteasomes were due to quantitative rather than qualitative differences in the spectrum of proteasome-generated antigenic peptides [33] . The repertoire of T cells is primarily formed in the thymus through positive and negative selection of developing thymocytes. After T cell receptor (TCR) rearrangement, developing thymocytes undergo the process of positive and negative selection, which is mediated by TCR-MHC-self peptide interaction. It is generally accepted that the proteasome is the main protease involved in generating class-I ligands for negative and positive selection. Distinct proteolytically active proteasome subunits have been described in the thymus [24] . Apart from the constitutive proteasome subunits β1c, β2c, and β5c the expression of the immunosubunits β1i, β2i, and β5i have been identified in the thymus [34] . Additionally, β1i, β2i, and β5t are expressed in cortical thymic epithelial cells (cTECs) building the so-called thymoproteasome [35] .
In this study, we describe a strongly reduced glycoprotein (GP) 118-125 -specific CTL response in LMP7-deficient mice infected with lymphocytic choriomeningitis virus (LCMV). We could show that this effect was not due to inefficient processing of this epitope, but due to a lack of GP 118-125 -specific precursors in LMP7-deficient mice. Since LMP7 is abundant in negatively selecting medullary thymic epithelial cells (mTECs) but not [34] or hardly [36, 37] detectable in positively selecting cTECs, our data suggests that LMP7 is required to prevent negative selection of GP 118-125 specific T cell precursors by so far unknown self antigens. Hence, we show that LMP7 is an important factor in determining the cytotoxic T cell repertoire and for filling up holes in the spectrum of T cell receptor specificities. responses between wild-type and LMP7-deficient mice could be observed. In contrast, the response to GP 118-125 was reduced to background levels in LMP7-deficient mice ( Fig. 1A and B) . In order to investigate whether the reduced GP 118-125 CTL response in LMP7 −/− mice is dependent on the virus type, we used a recombinant vaccinia virus expressing the LCMV glycoprotein (VVG2). Similar to LCMV, the GP 118-125 -specific CTL response in VVG2-infected LMP7 −/− mice was strongly reduced compared to wildtype mice (Fig. 1C) . Interestingly, as previously reported [8] , the GP 276-286 CTL response was increased in LMP7-deficient mice. It has been reported that LMP2 and MECL-1 incorporation into immunoproteasomes is strongly reduced in mice lacking LMP7 [38] . Hence, an altered incorporation of LMP2 and MECL-1 into immunoproteasomes of LMP7-deficient mice might contribute to the reduced GP 118-125 CTL response as seen in Fig. 1 . We have previously observed that the GP 118-125 response is not affected in MECL-1-deficient mice [13] . Analysis of LMP2-deficient mice showed a similar GP 118-125 response in wild-type and LMP2 deficient mice ( Fig. 2A) . Immunosubunit incorporation into 20S proteasomes can be influenced via the regulatory particle PA28αβ in PA28β
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−/− mice [39] , although these results could not be confirmed in mice lacking both PA28α and PA28β [40] . Moreover, PA28αβ was recently shown to preferentially associate with the immunoproteasome in vitro and in cells [41] . To investigate the contribution of PA28αβ to the GP 118-125 response, PA28α
mice were infected with LCMV-WE and the CTL response was analysed on d8 post infection (Fig. 2B) . No alteration of the GP 118-125 response could be observed in these mice, indicating that LMP7 alone is responsible for the reduced GP 118-125 response observed in LMP7-deficient mice (Fig. 1) .
GP 118-125 presentation is not altered by LMP7-deficient cells
In IFN-γ-stimulated cells, LMP2, MECL-1, and LMP7 are incorporated into newly synthesized proteasomes. We have previously shown that IFN-γ stimulation of cells led to a reduced presentation of the LCMV-derived T cell epitope GP [276] [277] [278] [279] [280] [281] [282] [283] [284] [285] [286] and to an increased GP [33] [34] [35] [36] [37] [38] [39] [40] [41] is not due to a different presentation of GP 118-125 on LMP7
It has been reported that the structural features rather than the proteolytic activity of an immunoproteasome subunit are required for the generation of certain epitopes [4, 10, 42] . Therefore, we tested whether the presentation of GP 118-125 is dependent on the catalytic activity of LMP7. To block LMP7-activity we used the well-described LMP7-selective inhibitor ONX 0914 (formerly designated PR-957) [17] (Fig. 4C and D) . However, GP 118-125 presentation was not affected when LMP7 activity was blocked. Additionally, when β5c activity in wild-type or LMP7-deficient macrophages was inhibited with the β5c-selective inhibitor PR-825 [17] , GP 118-125 presentation was not altered ( Fig. 4C and D) . Activity assays with a fluorogenic substrate for the chymotrypsin-like activity demonstrated that ONX 0914 and PR-825 were active in thioglycolate-elicited macrophages (Supporting Information Fig.  1A ). Hence, the chymotrypsin-like activity of the proteasome subunits LMP7 and β5c are not essential for GP 118-125 processing in macrophages.
To confirm these results in vivo, C57BL/6 wild-type mice were infected with LCMV-WE and treated with ONX 0914 or PR-825. The LCMV-specific T cell response was analysed on day 8 by ICS for IFN-γ ( active in mice (Supporting Information Fig. 1B) . As previously reported, ONX 0914 reduced the GP 33-41 response [9, 17] . Interestingly, β5c inhibition affected the GP 33-41 response at a comparable level (Fig. 5B) , indicating that both β5c-and LMP7-activity contribute to the GP 33-41 CTL response. Taken together, although a GP 118-125 -specific CTL response is lacking in LMP7-deficient mice ( Fig. 1 and Fig. 5C ), the proteolytic activity of LMP7 is not required for the generation of a normal GP 118-125 -specific response ( Fig. 5A and C).
Altered GP 118-125 -specific T cell repertoire in LMP7
−/− mice It has been reported that immunoproteasome-deficient mice might harbour an altered T cell repertoire [6, 13, 34, 43] . Since GP 118-125 presentation is not affected by LMP7-deficiency in macrophages, we intended to investigate whether LMP7-deficient mice have an altered GP 118-125 -specific T cell repertoire. To investigate whether LMP7 expression alters the T cell repertoire in the thymus, CD4 and CD8 single positive (SP) cells in the thymus were screened with a panel of antibodies specific for different Vβ-segments of the TCR (Supporting Information Fig. 2 ). When comparing SP thymocytes from wild-type and LMP7-deficient mice, only minor alterations in Vβ-segment usage were recorded for TCR-Vβ2 and TCR-Vβ3 in CD8 SP thymocytes and no alteration in TCR usage of CD4 SP T cells was observed. Hence, TCR-Vβ screening did not provide evidence that bulk T cell selection in the thymus is affected by LMP7. Similar findings were found by Osterloh et al. in the periphery in the spleen of LMP7-deficient mice [43] .
To test whether there is an impact of LMP7 on the generation of GP 118-125 -specific T cell precursors, we transferred wild-type Thy1. Fig. 3 ). It seems that the transferred cells have been rejected upon LCMV infection in LMP7-deficient mice. A similar result was observed when wild-type skin was transplanted to LMP7-deficient mice [7] . Conversely, a T cell transfer of LMP7-deficient T cells into wildtype mice is also not feasible to investigate the GP 118-125 -specific T cell repertoire since adoptively transferred immunoproteasomedeficient cells do not expand upon LCMV infection [14] . We decided to use bone marrow chimeras as an alternative approach. Wild-type or LMP7-deficient mice were irradiated and reconstituted with either wild-type or LMP7-deficient bone marrow. 8 weeks post reconstitution, mice were infected with LCMV-WE and the GP 33-41 -and GP 118-125 -specific T cells response in the spleen was analysed 8 days later (Fig. 6) . No difference in the GP 33-41 -specific CTL response was observed for all the analysed bone marrow chimeras. In contrast, irrespective whether LMP7 −/− mice were reconstituted with wild-type or LMP7 −/− bone marrow, these mice were not able to mount a GP 118-125 -specific T cell response suggesting that the expression of LMP7 in a radioresistant cell type is necessary for the generation of GP 118-125 -specific CTLs (Fig. 1) . Since professional antigen presenting cells (APCs) are inducing the LCMV-specific CTL response [44] , we assume that an influence of LMP7 on priming of GP 118-125 -specific T cells can be excluded in LMP7 −/− mice reconstituted with wild-type bone marrow. Additionally, wild-type mice reconstituted with LMP7-deficient bone marrow mounted a normal GP 118-125 response, indicating that LMP7-deficient GP 118-125 -specific T cells are able to expand and LMP7-deficient APCs can process and present this peptide. These data strongly argue for an altered precursor frequency of GP 118-125 -specific T cells in LMP7-deficient mice. 
To address this question, magnetically sorted CD8
+ T cells from naïve LMP7-deficient or wild-type mice were adoptively transferred into RAG1 −/− mice. Three weeks after homeostatic expansion of the transferred CD8 + T cells, the mice were infected with LCMV-WE and the GP [33] [34] [35] [36] [37] [38] [39] [40] [41] , NP 205-212 and GP 118-125 -specific T cell response was analysed by ICS for IFN-γ (Fig. 7) . Both, transferred wild-type and LMP7-deficient CD8 + cells, mounted a comparable GP 33-41 -or NP 205-212 -specific T cell response. However, GP 118-125 -specific CD8 + T cells derived from LMP7 −/− mice, in contrast to wild-type mice, were not able to expand upon LCMV infection. This result indicates that LMP7-deficient mice lack GP 118-125 -specific precursor CD8 + T cells.
Discussion
The immunoproteasome is critically involved in the generation of MHC-I restricted epitopes [11, 12, 24] . Infection of LMP7-deficient mice with LCMV showed a reduced GP 118-125 -specific CTL response (Fig. 1) . Interestingly, a similar result was observed in LCMV-infected triply immunoproteasome-deficient mice [11] . In contrast, the GP 118-125 -specific CTL response in LMP2-( Fig. 2A) or MECL-1-deficient [13] mice was comparable to wild-type mice, indicating that LMP2 and MECL-1 do not influence the GP 118-125 -specific CTL response. Furthermore, LCMV infection of LMP2 −/− /MECL-1 −/− double-deficient mice treated with the welldefined LMP7-selective inhibitor ONX 0914 to generate mice lacking the activity of all immunoproteasome subunits induced a normal GP 118-125 -specific CTL response [9] . This result suggests that the proteolytic activity of LMP7 during LCMV infection is dispensable to elicit a GP 118-125 -specific CTL response. Indeed, we could confirm this result in wild-type mice treated with the LMP7-selective inhibitor ONX 0914 (Fig. 5) . It has been shown that structural features rather than the proteolytic activity of an immunoproteasome subunit are needed for the generation of certain epitopes [4, 42] . Recently, we provided a rationale why the structural property of an immunoproteasome subunit rather than its activity is required for the generation of a CTL epitope [10] . Namely, CTL epitopes, which are destroyed by constitutive proteasome subunits, are simply protected from destruction by the incorporation of their homologous immunoproteasome subunit, which do not exert the destructive cleavage. To test whether the constitutive β5c proteasome subunit destroys the GP 118-125 CTL epitope, macrophages or mice were treated with the β5c-selective inhibitor PR-825 [17] . Neither in vitro ( Fig. 4C and D) nor in vivo (Fig. 5) a destruction of GP 118-125 by β5c could be observed. GP 118-125 presentation by LMP7-deficient macrophages and dendritic cells was unaltered ( Fig. 4A and B) , indicating that LMP7 is not required for the processing of this CTL epitope. Taken together, GP 118-125 presentation in LMP7-deficient cells is not altered, the catalytic activity of LMP7 is not required for the generation of this epitope, β5c does not destroy GP [118] [119] [120] [121] [122] [123] [124] [125] , and the processing of this epitope is not influenced by other immunoproteasome subunits. Why then is the GP 118-125 -specific CTL response altered in LMP7-deficient mice? The normal processing of GP [118] [119] [120] [121] [122] [123] [124] [125] (Fig. 4) suggests that LMP7-deficient mice lack GP 118-125 precursor T cells. Immunoproteasome subunits are constitutively expressed in the thymus [34, 35] . According to Nil et al., immunoproteasome subunits are expressed in thymic DCs, thymic macrophages, and mTECs. No mRNA expression, neither for MECL-1, LMP2, nor LMP7, could be detected in cTECs. In contrast, Murata et al. found MECL-1 and LMP2 expression in cTECs, but only a weak LMP7 expression [35] . Instead of LMP7, β5t is incorporated into MECL-1 and LMP2 containing thymoproteasomes. β5t-deficient mice have a disturbed development of CD8 + T cells in the thymus [35] leading to a markedly altered T cell receptor repertoire that is defective in both allogeneic and antiviral responses [36] . It is assumed that thymoproteasomes support positive selection by generating peptides optimized for the selection of weakly self-reactive, naïve T cell clones [37] . Since immunoproteasome subunits are also expressed in thymic cells they might influence positive and negative selection processes by producing an altered MHC-I peptidome.
Indeed, several studies have demonstrated that immunoproteasomes determine the CTL repertoire [6, 13, 34, 43, 45, 46] . Osterloh et al. found that one of the self-peptides responsible for positive selection of transgenic ovalbumin-specific OT-I T cells, which is derived from the F-actin capping protein (Cpalpha1), is efficiently generated only by immunoproteasomes [43] . Furthermore, OT-I mice lacking LMP7 expression showed a 50% reduction of SIINFEKL-specific T cells. This data indicate that LMP7 can influence the naïve T cell repertoire. Nevertheless, since cTECs are mediating positive selection [47] and express β5t [35] it remains elusive how LMP7 can influence positive selection. Adoptive transfer experiments in LMP2-deficient mice revealed that the reduced immunogenicity of the influenza A virus-derived epitope NP [366] [367] [368] [369] [370] [371] [372] [373] [374] can be attributed to alterations in the CTL repertoire and not to the decreased capacity of LMP2 −/− APCs to generate this CTL epitope. The frequency of influenza PA 224-233 -specific CTLs is intact in MECL1 −/− but impaired in LMP2 −/− and LMP7 −/− /MECL1
−/− mice [45] . In the LCMV system, an alteration in the T cell repertoire was described by the means of two different T cell epitopes [13, 34] . The number of CD4 + 8 + GP 33-41 -specific transgenic P14-
T cells was markedly reduced in the thymus of P14-tg LMP2
−/− mice compared to P14-tg LMP2-proficient mice [34] . In MECL-1-deficient mice, the reduced GP 276-286 -specific T cell response could be attributed to an altered T cell repertoire in these mice [13] . On a first glance, the reduced number of CD8 + cells found in the spleen of MECL-1-deficient mice [13] might be attributed to an altered thymic T cell selection, but experiments with bone marrow chimeras demonstrated this to be a T cell intrinsic phenomenon due to altered homeostatic proliferation of T cells [48] . Recently, Kincaid et al. crossed mice lacking all three immunoproteasome subunits with mice lacking the thymosubunit β5t to generate mice lacking all four specialized proteasome β-subunits (4KO mice) [46] . These mice, expressing only constitutive subunits in all cells, had a profound defect in the generation of CD8 + T cells. Analysis of T cell development in the 4KO mice revealed an impaired positive and negative selection in the thymus. This is consistent with a peptide-switching model wherein developing CD8 + T cells need to be positively and negatively selected on different peptides for the establishment of a broad TCR repertoire. Thus, thymoproteasomes in cTECs produce unique peptides for positive selection, whereas negative selection occurs on peptides produced by constitutive, immunoproteasomes, or mixed proteasomes. Using bone marrow chimeras (Fig. 6 ) and adoptive T cells transfer (Fig. 7) we could show that LMP7-deficient mice lack GP 118-125 -specific T cell precursors. How can LMP7 affect the GP 118-125 -specific T cell repertoire? Since LMP7 in the thymus is mainly expressed in cells mediating negative selection, we speculate that proteasomes lacking LMP7 in these cells generate a selfpeptide mediating negative selection of GP 118-125 -specific T cells. TCRs specific for a viral MHC-I-peptide complex can cross-react with multiple other MHC-I-peptide complexes, including selfpeptides [49] . The cross-reactivity rather depends on similarities in the three-dimensional structure of the MHC-I-peptide complex and can be unrelated to the primary sequence [50] . Immunoproteasomes are induced during inflammation. Thus, the expression of immunoproteasomes in cells mediating negative selection helps to eliminate potential autoreactive T cells recognizing self-antigen in inflamed tissues. Nevertheless, since minute LMP7 expression was detected in cTEC preparations [35, 37, 51] we cannot completely rule out that LMP7 affects also positive selection of GP 118-125 -specific T cells.
Our data support the idea that LMP7 is an important factor for filling up holes in the spectrum of T cell receptor specificities. A "hole" in the T cell repertoire may represent an important mechanism of viral persistence. Indeed, hepatitis C virus (HCV) immune escape can occur via exploitation of a hole in the T cell repertoire [52] . Although HCV elicits a substantial virus-specific immune response, HCV frequently persists. Wölfl et al. report for a naturally occurring mutation in a human CD8 + T cell epitope that only affects TCR contact without altering peptide processing or MHC affinity. Due to a hole in the naïve T cell repertoire, CD8 + T cells recognizing this escape variant peptide are lacking in most individuals. Taken together, the lack of immunoproteasome in the thymus can lead to the elimination of virus-specific T cell precursors. Hence, we describe the immunoproteasome as a crucial factor in determining and completing the CTL repertoire.
Materials and methods
Mice, viruses, and media C57BL/6 mice (H-2 b ) were originally purchased from Charles River, Germany. MECL-1 [13] , LMP2 [53] , and LMP7 [32] Invitrogen-Life Technologies (Karlsruhe, Germany) and contained GlutaMAX, 10% FCS, and 100 U/mL penicillin/streptomycin.
Synthetic peptides
The synthetic peptides GP [33] [34] [35] [36] [37] [38] [39] [40] [41] 
Proteasome inhibitor
Proteasome inhibitors were used as previously described [22] . Shortly, inhibitors specific for β5i (ONX 0914; formerly called PR-957) and β5c (PR-825) were obtained from Onyx Pharmaceuticals. Both inhibitors were dissolved at a concentration of 10 mM in DMSO and stored at −20°C [17] . For proteasome inhibition in mice, ONX 0914 was formulated in an aqueous solution of 10% (w/v) sulfobutylether-ß-cyclodextrin and 10 mM sodium citrate (pH 6) and administered to mice as an s.c. bolus dose of 10 mg/kg (in a volume of 100 μL). PR-825 was dissolved in 2% ethanol in saline and administered as an s.c. bolus dose of 2 mg/kg (in a volume of 100 μL) in mice.
Intracellular cytokine staining (ICS)
Analysis of T cell responses was performed as previously detailed [2, 56] . Briefly, splenocytes (1 × 10 6 ) were incubated in roundbottom 96-well plates with 10 −6 M of the specific peptide in 100 μL IMDM 10% FCS + brefeldin A (10 μg/mL) for 5 h at 37°C. A neubauer chamber was used for counting. The staining, fixation, and permeabilization of the cells was performed exactly as detailed previously [8] . Cells were acquired with the use of the BD Accuri TM C6 flow cytometer system or BD FACSCalibur TM and analyzed with the FlowJo software (Tree Star). 100 000 lymphocytes (gated according to FSC/SSC) were acquired. Gating strategy is indicated in Fig. 1 . Background IFN-γ production (without peptide stimulation) was between 0.1 and 0.6 as indicated. Raw data can be provided per request. The ICS was performed using well established laboratory protocols.
Adoptive transfer
Adoptive transfer was performed as previously described [13] . 
Antigen presentation assays
Antigen presentation assay and generation of LCMV-specific CTLlines were performed as previously described [13, 55] . An additional density centrifugation step was conducted 1-2 days before using CTLs in antigen presentation experiments. For thioglycolateelicited macrophages, CTLs were used in ICS at an E:S ratio of 0.2 in the first dilution and subsequent serial 3-fold dilution of stimulators. CD11c + dendritic cells from splenocytes of LCMV-infected C57BL/6 or LMP7 −/− mice were magnetically isolated with CD11c
MicroBeads (Miltenyi Biotec). CTLs were used in ICS at an E:S ratio of 1.
Proteasome immunoprecipitation
Immunoprecipitation was performed as previously described [57] . Shortly, after extensive washing, equal amounts of macrophages or splenocytes were lysed and incubated with three microliters of polyclonal rabbit anti-mouse proteasome Ab [58] and 50 μL protein A microbeads (Miltenyi Biotec) for 30 min on ice. The lysate was applied to the microcolumn (Miltenyi Biotec), and the column was washed five times. Then, 50 μL fluorogenic peptide substrate (Suc-LLVY-AMC; Bachem) was applied to the column at a concentration of 100 μM. The μ column was incubated at 37°C for 30 min. A total of 100 μL lysis buffer was added, and the fluorescence intensity in the eluate was measured at an excitation wavelength of 360 nm and emission wavelength of 465 nm on a fluorescence plate reader (Infinite M200 pro, TECAN).
Generation of bone marrow chimeras
Generation of bone marrow chimeras was performed as previously described [22] . Shortly, age-and sex-matched LMP7 −/− or C57BL/6 recipient mice were lethally irradiated with 9.8 Gy and received 3 × 10 6 bone marrow cells from age-and sex-matched LMP7 −/− or C57BL/6 donor mice on the same day by i.v. injection.
Mice were rested 8 weeks before use in experiments.
TCR Vβ expression
TCR Vβ expression analysis was performed as previously described [59] . Shortly, thymocytes were screened for TCR Vβ expression by flow cytometry using PE-conjugated CD4 (GK1.5) and APCconjugated CD8 (53-6.7) antibodies (both eBioscience, Frankfurt, Germany) in conjunction with a Vβ TCR screening panel (Becton Dickinson, Heidelberg, Germany) according to the manufacturer's instructions.
Statistical analysis
Statistical analysis was performed as previously described [56] . Shortly, the statistical significance was determined using unpaired Student t test. All statistical analyses were performed using GraphPad Prism Software (version 4.03) (GraphPad, San Diego, CA). Statistical significance was achieved when p<0.05. *p<0.05; **p<0.01; ***p<0.001. If not indicated, data sets did not show significant differences.
